FEBS Open Bio is a leading open-access journal published by Wiley, dedicated to advancing our understanding of biochemistry, genetics, and molecular biology. Since its inception in 2011, this journal has provided a robust platform for researchers to share their findings with a wider audience, ensuring the dissemination of high-quality scientific knowledge. With an impact factor reflecting its stature in its field, FEBS Open Bio is ranked #77 out of 221 in general biochemistry, genetics, and molecular biology, placing it in the 65th percentile among its peers. This journal serves as an essential resource for professionals, researchers, and students alike, fostering collaboration and innovation within the scientific community. The commitment to open access not only enhances visibility but also promotes transparency in research, making it a vital contributor to the ongoing dialogue in biochemical and molecular biological sciences. For those looking to stay at the forefront of research developments, FEBS Open Bio is a key publication addressing the latest trends and discoveries in the field.

EXPERIMENTAL AND MOLECULAR MEDICINE, published by SpringerNature, is a premier open-access journal that has been at the forefront of biomedical research since its establishment in 1996. With a focus on innovative studies in biochemistry, molecular biology, and clinical biochemistry, the journal has consistently maintained a distinguished position within the top quartile (Q1) across multiple categories, underscoring its significant impact in these fields. The journal offers researchers and practitioners a platform for high-quality, peer-reviewed articles that advance our understanding of molecular mechanisms underlying health and disease. As a crucial resource for scholars seeking to explore cutting-edge research and practical advancements, its inclusion in relevant databases such as Scopus reflects an exceptional ranking with notable percentiles—placing it among the best in biomedical sciences. With a commitment to open access, EXPERIMENTAL AND MOLECULAR MEDICINE ensures that findings are readily available to the global academic community, facilitating collaboration and innovation in molecular medicine.

JOURNAL OF EXPERIMENTAL BIOLOGY, published by COMPANY BIOLOGISTS LTD, stands as a cornerstone in the fields of Animal Science, Aquatic Science, Ecology, Insect Science, and Physiology. With a rich history dating back to 1945, this esteemed journal has continually provided a platform for high-quality research, evidenced by its impressive Q1 rankings across multiple categories in the 2023 Journal Citation Reports. Located in the United Kingdom, it serves an international audience, offering critical insights and advancements in various biological sciences. As a non-open access journal, it provides rigorous peer-reviewed articles that contribute profoundly to our understanding of biological processes and their implications. With an extensive reach among researchers, practitioners, and academia, the JOURNAL OF EXPERIMENTAL BIOLOGY is not only a repository of knowledge but also a catalyst for ongoing research and innovation in experimental biology.

BMC Biology, a prominent open access journal published by BMC since 2003, offers a dynamic platform for the dissemination of research in the fields of biology, biochemistry, and biotechnology. Based in the United Kingdom, this journal showcases high-impact studies that cover a broad range of topics including cell biology, developmental biology, ecology, and structural biology, reflecting its commitment to advancing knowledge in the life sciences. With an impressive record of Q1 rankings across multiple categories in 2023, including Agricultural and Biological Sciences and Biochemistry, Genetics and Molecular Biology, BMC Biology stands out as a leader in these disciplines. Researchers will find a robust forum for innovative and high-quality research due to its substantial Scopus rankings, which place it within the top 10% of its field. The journal's open access policy facilitates widespread dissemination, ensuring that critical biological research is accessible to a diverse global audience. Whether you are a researcher, student, or professional in the biological sciences, BMC Biology is essential for staying informed about the latest advancements and developments in this ever-evolving field.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, published by Elsevier, is a pivotal journal in the fields of Molecular Biology and Molecular Medicine, recognized for its high impact factor and robust ranking within Scopus categories, holding prestigious quartiles in Q1 for both disciplines as of 2023. With ISSN 0925-4439 and E-ISSN 1879-260X, this journal fosters cutting-edge research from 1990 to 2025, addressing the critical molecular mechanisms underlying human diseases. Its wide-ranging scope includes original research articles, reviews, and advanced theoretical insights, serving as an essential resource for researchers, clinicians, and students alike. The journal is based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, and while it does not currently offer an open-access option, it continues to maintain a strong presence in the scientific community, enhancing our understanding of molecular processes in health and disease.

eLife is a premier open-access journal that stands at the forefront of biological and medical research, published by eLIFE SCIENCES PUBL LTD in the United Kingdom. Since its inception in 2012, the journal has made significant strides in disseminating high-quality research across various key disciplines, including Biochemistry, Genetics and Molecular Biology, Immunology and Microbiology, and Neuroscience, maintaining a prestigious Q1 quartile ranking in all these fields as of 2023. With an impressive Scopus ranking placing it among the top-tier journals—12th in General Neuroscience, 24th in General Biochemistry, and 8th in General Immunology—eLife is recognized for its impact and influence in shaping research narratives. As an open-access journal, eLife facilitates global access to groundbreaking scientific discoveries, fostering collaboration and innovation among researchers, professionals, and students alike. With a commitment to rigorous peer review and publication excellence, eLife is not just a journal; it is a vital platform contributing to the advancement of life sciences.

BIOLOGY OF THE CELL is a prominent academic journal published by Wiley, dedicated to advancing the field of cellular biology through the dissemination of innovative research and insights. With its ISSN (0248-4900) and E-ISSN (1768-322X), this journal has been a vital resource since its inception in 1981 and is set to continue its scholarly contributions until 2024. Positioned within the Q3 quartile in Cell Biology and Q2 in Medicine (miscellaneous) as of 2023, BIOLOGY OF THE CELL is recognized for its rigorous peer-review process and its commitment to high-quality publication in critical areas such as biochemistry, genetics, and molecular biology. Although the journal does not currently offer open access options, it remains accessible through the Wiley platform, ensuring that researchers, professionals, and students can benefit from its rich repository of knowledge. By linking fundamental cellular processes with broader medical implications, this journal serves as a critical platform for fostering dialogue and innovation in cellular research, making it an essential read for anyone engaged in the life sciences.

Journal of Biological Research-Thessaloniki, published by Aristotle University of Thessaloniki, is a distinguished academic journal committed to advancing the fields of Agricultural and Biological Sciences and Biochemistry, Genetics and Molecular Biology. As an Open Access journal since 2004, it provides a platform for the rapid dissemination of innovative research that spans diverse biological disciplines. With an impact factor that situates it in the Q2 category for Agricultural and Biological Sciences and Q3 for Biochemistry, Genetics and Molecular Biology as of 2023, the journal demonstrates a significant contribution to its respective fields. Located in Thessaloniki, Greece, it serves a global audience of researchers, professionals, and students eager to access quality scientific content. The journal is dedicated to publishing original research articles, reviews, and critical commentaries, encouraging collaboration and dialogue amongst scientists dedicated to the frontiers of biological research.

Cell Reports Methods is a cutting-edge journal published by CELL PRESS, focusing on innovative methodologies in the vast fields of biochemistry, genetics, biotechnology, and radiological sciences. Launched in 2021, it has rapidly ascended to attain a Q1 ranking across multiple disciplines in the latest 2023 metrics, reflecting its influential contribution to the scientific community. With an emphasis on practical and rigorous experimental approaches, this journal serves as a vital resource for researchers looking to advance their methodologies and collaborate on significant findings in their respective specialties. Despite not being an open-access publication, Cell Reports Methods ensures broad accessibility through institutional subscriptions, allowing researchers from various backgrounds to engage with high-quality scholarly work. The journal presents a unique platform for sharing insights from interdisciplinary methods that foster innovation and discovery, ultimately shaping the future of scientific research.

Science China-Life Sciences, published by SCIENCE PRESS, is a premier academic journal that stands at the forefront of innovative research and discoveries in the fields of life sciences, spanning crucial areas such as agricultural and biological sciences, biochemistry, genetics, molecular biology, and environmental science. With an impressive Q1 ranking in its respective categories—ranked #5 in Agricultural and Biological Sciences, #7 in Environmental Science, and #17 in Biochemistry, Genetics and Molecular Biology—this journal is recognized for its rigorous peer-review process and significant impact within the scientific community, as reflected in its high percentiles (97th and 92nd). Maintained as an Open Access publication, it ensures broad dissemination and accessibility of research findings, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. Given its position in the research landscape and its commitment to high-quality scholarship, Science China-Life Sciences plays a vital role in advancing life sciences research, supporting scientists in addressing global challenges through innovative biological solutions.